Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
BFNHBioforce Nanosciences Holdings, Inc.
Filed Nov 3, 2023 · 10-Q · 34 days after period end · 0001091818-23-000181
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$113.61K | -$122.59K | -$113.86K | -$117.92K |
| EPS Diluted | $0.00 | $0.00 | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 3, 2023 · 34 d after period end
